Artificial intelligence is accelerating the drug development process by identifying potential drug candidates and predicting their efficacy. AI models can sift through enormous datasets to identify compounds that might be effective against specific cancer types. Additionally, AI can simulate clinical trials, reducing the time and cost associated with bringing new cancer treatments to market.